Evidence map›Paper›PMID 36358461›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson's Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway.

Ru-Huei Fu, Chia-Wen Tsai, Shih-Ping Liu, Shao-Chih Chiu, Yen-Chuan Chen, Yu-Ting Chiang, Yun-Hua Kuo, Woei-Cherng Shyu, Shinn-Zong Lin

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. UnveilingInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ru-Huei FuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0001-9367-1759
Chia-Wen TsaiDepartment of Nutrition, China Medical University, Taichung 40402, Taiwan.
Shih-Ping LiuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Shao-Chih ChiuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Yen-Chuan ChenGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Yu-Ting ChiangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Yun-Hua KuoGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Woei-Cherng ShyuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
Shinn-Zong LinBuddhist Tzu Chi Bioinnovation Center, Tzu Chi Foundation, Hualien 97002, Taiwan.ORCID 0000-0002-4601-9933
China Medical University · TWTzu Chi Foundation · TW

Funding

China Medical University Hospital (Taiwan) DMR-110-132Ministry of Science and Technology (Taiwan) MOST 110-2314-B-039-040-
6 · The paper itself

Abstract

We assessed the antioxidant potential of narcissoside from

Indexed as

6-hydroxydopamineapoptosisC. elegansglutathioneMAPKmiR200anarcissosideNrf2Parkinson diseaseSH-SY5Y

Identifiers

PMID36358461
PMCPMC9686521
OpenAlexW4307327609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.